Blog
CLARINESS supports COVID-19 studies
Clariness is doing its part to support and accelerate the world-wide release of a safe Covid-19 vaccine through its patient recruitment services for clinical trials.
What Do Patients Want from a Clinical Trial?
What do patients want from a clinical trial? It can be broadly broken down into three categories, this blog explores these concepts further and also highlights why the patient voice is so important…
What Patient Recruitment Support Do Leaders Want and Need?
Do you want to know what the biggest patient recruitment challenges faced by industry and investigators are? This blog sheds some light on what clinical trial leaders want…
How technology is delivering the right patient for the study
Are you using technology to get the right patient for your study? Read this blog to understand the power of technology and how it can improve your clinical trial recruitment challenges…
Patient-centric ways to secure study feasibility
How can patient-centricity ensure your planned study is feasible? The answer is simple: patient-centric studies are more feasible because they are attractive, convenient, engaging, and understanding of patient needs…
Why international studies need a vendor with international experience
The volume of international studies is growing, with the market for global clinical trials expected to be worth $65.2 billion by 2025.1 Some of the key drivers of the increased globalization of clinical studies include the expanding R&D investments by drug developers in emerging health markets…
Why designing a modern study protocol can save your clinical trial
There is a growing interest in therapeutic advancements in genomics medicine, orphan drugs, and precision medicine. This interest has driven the need to generate robust clinical findings that can set a momentum for stakeholder acceptance of newly approved treatments. Yet many clinical trials continue struggle to generate quality trial results as they deal with clinical development inefficiencies and ballooning costs.
Budgeting for patient recruitment strategies in clinical trials
Patient recruitment costs vary between therapeutic areas, but consistent across diseases is the significant share of a trial budget required to recruit the appropriate participants. Yet in our recent ‘Innovation in Patient Recruitment’ survey, 41% of respondents with buying power had no budget specifically for recruiting participants for research.
Correct study planning: Avoiding delays and achieving success in your clinical trials
Pharmaceutical companies of today are under increasing pressure to fully demonstrate the safety, effectiveness, and economic value of new medicines. The industry shift towards precision medicine and outcomes-based assessments also puts pressure on researchers to address the growing complexity of clinical study protocols. Failure to manage this complexity could compromise the integrity of your clinical studies, slow down the momentum of drug development, all leading to delay in approvals.
Patient-centricity: How can it benefit your clinical study?
Patient-centricity is a critical component of a successful clinical trial, which can improve patient enrollment and retention. It helps overcome the many challenges faced by study teams by addressing the growing demands of an evolving patient population – who are actively engaged in their healthcare.
